Related Articles
The official website of the Nobel Prize – NobelPrize.org
“When I meet patients who tell me: ‘You saved my life,’ it is an unforgettable moment.” Read about laureates James P. Allison and Tasuku Honjo…
A Gentle Introduction to Spatial Transcriptomic Analysis with 10X Visium Data
Spatial transcriptomics (ST) combines single-cell RNA-seq gene expression data with spatial coordinates to provide an accurate, 2D picture of gene expression across a tissue sample.…
Reprogramming of Androgen Receptor Activity in Castration-resistant Prostate Cancer is Shaped by Truncated Variants
The androgen receptor (AR) is a master regulator in prostate cancer, but the relevance of its truncated variants remains unclear. Using patient-derived models, we demonstrated…
High-purity CTC RNA sequencing identifies prostate cancer lineage phenotypes prognostic for clinical outcomes
Abstract. The development of treatment resistance remains universal for patients with metastatic prostate cancer, driven by AR alterations and lineage state transitions. Identifying the evolution…
High-purity CTC RNA sequencing identifies prostate cancer lineage phenotypes prognostic for clinical outcomes
Abstract. The development of treatment resistance remains universal for patients with metastatic prostate cancer, driven by AR alterations and lineage state transitions. Identifying the evolution…
Stem-like memory and precursors of exhausted T cells share a common progenitor defined by ID3 expression
ID3 defines stem-like T cells with high developmental potential that sustain T cell responses to chronic infection and cancer.
AtlasXomics Inc. on LinkedIn: #epigenetics #genomics
Cheers to a year of breakthroughs at Atlasxomics—and an even more innovative 2025 ahead! Together, let’s push the boundaries of discovery. #epigenetics…
Drug-Induced Epigenomic Plasticity Reprograms Circadian Rhythm Regulation to Drive Prostate Cancer toward Androgen Independence – PubMed
Understanding how prostate cancers adapt to AR-targeted interventions is critical for identifying novel drug targets to improve the clinical management of treatment-resistant disease. Our study…
Toni Choueiri: Honored by the King Hussein Cancer Foundation – OncoDaily
Toni Choueiri: Honored by the King Hussein Cancer Foundation / cancer, Dana-Farber Cancer Institute, DFCI, HRH Princess Ghida Talal, King Hussein Cancer
Toni Choueiri: Honored by the King Hussein Cancer Foundation – OncoDaily
Toni Choueiri: Honored by the King Hussein Cancer Foundation / cancer, Dana-Farber Cancer Institute, DFCI, HRH Princess Ghida Talal, King Hussein Cancer